These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2944130

  • 1. Locomotor hyperactivity: effects of multiple striatal transplants in an animal model of Huntington's disease.
    Sanberg PR, Henault MA, Deckel AW.
    Pharmacol Biochem Behav; 1986 Jul; 25(1):297-300. PubMed ID: 2944130
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease.
    Borlongan CV, Koutouzis TK, Poulos SG, Saporta S, Sanberg PR.
    Cell Transplant; 1998 Jul; 7(2):131-5. PubMed ID: 9588595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting.
    Isacson O, Brundin P, Gage FH, Björklund A.
    Neuroscience; 1985 Dec; 16(4):799-817. PubMed ID: 2936982
    [Abstract] [Full Text] [Related]

  • 12. Graft-induced behavioral recovery in an animal model of Huntington disease.
    Isacson O, Dunnett SB, Björklund A.
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2728-32. PubMed ID: 2939457
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human fetal striatal transplantation in an excitotoxic lesioned model of Huntington's disease.
    Sanberg PR, Borlongan CV, Koutouzis TK, Norgren RB, Cahill DW, Freeman TB.
    Ann N Y Acad Sci; 1997 Dec 31; 831():452-60. PubMed ID: 9616734
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF, Winn SR, Hantraye PM, Peschanski M, Chen EY, Chu Y, McDermott P, Baetge EE, Kordower JH.
    Nature; 1997 Mar 27; 386(6623):395-9. PubMed ID: 9121555
    [Abstract] [Full Text] [Related]

  • 18. Fetal striatal tissue grafts into excitotoxin-lesioned striatum: pharmacological and behavioral aspects.
    Norman AB, Giordano M, Sanberg PR.
    Pharmacol Biochem Behav; 1989 Sep 27; 34(1):139-47. PubMed ID: 2626445
    [Abstract] [Full Text] [Related]

  • 19. [Behavior characterization of a model of Huntington's disease in rats, induced by quinolinic acid].
    Francis L, Cruz R, Antúnez I, Rosillo JC.
    Rev Neurol; 1989 Sep 27; 30(11):1016-21. PubMed ID: 10904945
    [Abstract] [Full Text] [Related]

  • 20. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC, Hantraye P, Dolan R, Palfi S, Maziére M, Brouillet E.
    Neuroscience; 1997 Jul 27; 79(1):45-56. PubMed ID: 9178864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.